Skip to main content

Petros Pharmaceuticals, Inc. (PTPI)

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Last price
$0.00
As of

Kresmion compiles this page from PTPI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Petros Pharmaceuticals, Inc. (PTPI): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-30.

As of . Source: SEC EDGAR filings for PTPI. Method and limitations.

COMPANY DOSSIER

See the full PTPI dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for PTPI on one page. Preview it with sample data, then open it live with a free account.

Preview the PTPI dossier

Active events for PTPI

  • mediumEarnings below estimates

    Q4-2023: Missed consensus by 102.3% - EPS $-57.25 vs $-28.305 estimate

  • mediumEarnings below estimates

    Q1-2024: Missed consensus by 15.1% - EPS $-42.25 vs $-36.72 estimate

  • mediumEarnings above estimates

    Q2-2024: Beat consensus by 52.9% - EPS $-9.25 vs $-19.635 estimate

  • mediumEarnings below estimates

    Q3-2024: Missed consensus by 79.2% - EPS $-13.25 vs $-7.395 estimate

  • mediumEarnings below estimates

    Missed consensus by 102.3% - EPS $-57.25 vs $-28.305 estimate

FREE, NO ACCOUNT

Every event on PTPI, as it fires

You are seeing 5 of 8 events recorded on PTPI since 2026-05-27.

The five above landed across 2 days. The other 3 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, PTPI

Going concern statement

PTPI's 10-Q filed Aug 13, 2026 states:

These conditions and events raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on PTPI

Cite this data

Kresmion counts the managers it follows that reported a non-option position in PTPI on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on PTPI in the last 180 days.

Upstream: SEC EDGAR filings for PTPI

Kresmion, "Petros Pharmaceuticals, Inc. (PTPI) institutional holdings and SEC filings", data as of 2026-09-30, https://kresmion.com/research/PTPI. Upstream data: SEC EDGAR filings for PTPI.

Link to this data (HTML):

<a href="https://kresmion.com/research/PTPI">Petros Pharmaceuticals, Inc. (PTPI) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow PTPI on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to PTPI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the PTPI dossier
Share

The PTPI intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.